KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Total Liabilities (2016 - 2026)

Supernus Pharmaceuticals has reported Total Liabilities over the past 15 years, most recently at $390.9 million for Q4 2025.

  • Quarterly Total Liabilities rose 17.63% to $390.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $390.9 million through Dec 2025, up 17.63% year-over-year, with the annual reading at $390.9 million for FY2025, 17.63% up from the prior year.
  • Total Liabilities was $390.9 million for Q4 2025 at Supernus Pharmaceuticals, up from $370.1 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $879.7 million in Q1 2023 and troughed at $316.6 million in Q1 2025.
  • The 5-year median for Total Liabilities is $382.9 million (2024), against an average of $562.9 million.
  • Year-over-year, Total Liabilities skyrocketed 30.62% in 2021 and then plummeted 57.38% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $873.3 million in 2021, then fell by 6.53% to $816.3 million in 2022, then plummeted by 56.37% to $356.2 million in 2023, then decreased by 6.69% to $332.3 million in 2024, then increased by 17.63% to $390.9 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Total Liabilities are $390.9 million (Q4 2025), $370.1 million (Q3 2025), and $318.5 million (Q2 2025).